BNP Paribas Financial Markets
ELOX

BNP Paribas Financial Markets’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

BNP Paribas Financial Markets’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12
Closed -$83 – 4951
2022
Q3 		$83 Hold
12
– – ﹤0.01% 4657
2022
Q2 		$132 Hold
12
– – ﹤0.01% 4012
2022
Q1 		$274 Sell
12
-4
-25% -$79 ﹤0.01% 4070
2021
Q4 		$457 Sell
16
-2
-11% -$87 ﹤0.01% 4118
2021
Q3 		$1.18K Hold
18
– – ﹤0.01% 3859
2021
Q2 		$1.44K Sell
18
-65
-78% -$5.42K ﹤0.01% 3913
2021
Q1 		$11.1K Sell
83
-45
-35% -$6.88K ﹤0.01% 3825
2020
Q4 		$20.4K Sell
128
-34
-21% -$4.15K ﹤0.01% 3844
2020
Q3 		$17K Buy
162
+114
+238% +$13.7K ﹤0.01% 3876
2020
Q2 		$5.76K Sell
48
-147
-75% -$16.6K ﹤0.01% 3947
2020
Q1 		$15.3K Buy
195
+94
+93% +$15.3K ﹤0.01% 3966
2019
Q4 		$29.6K Buy
101
+10
+11% +$2.02K ﹤0.01% 3888
2019
Q3 		$16.4K Buy
91
+28
+44% +$7.96K ﹤0.01% 4038
2019
Q2 		$25.1K Sell
63
-54
-46% -$22.7K ﹤0.01% 3817
2019
Q1 		$54.6K Buy
+117
New +$56.8K ﹤0.01% 3450
2018
Q4 		– Sell
-18
Closed -$12K – 4473
2018
Q3 		$12K Hold
18
– – ﹤0.01% 3648
2018
Q2 		$12K Buy
+18
New +$11.7K ﹤0.01% 3703

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BNP Paribas Financial Markets's ELOX Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 12 shares — an estimated $83 sold.

BNP Paribas Financial Markets first reported a position in ELOX in Q2 2018 and held it in 17 quarters. The position peaked at $54.6K in Q1 2019. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 12 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $83.
  • BNP Paribas Financial Markets first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 17 quarters.
  • BNP Paribas Financial Markets's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $54.6K in Q1 2019.
  • 19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.